EP3974446 - ANTI-HEPATITIS B VIRUS ANTIBODIES AND USE THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 25.02.2022 Database last updated on 06.07.2024 | |
Former | The international publication has been made Status updated on 27.11.2020 | Most recent event Tooltip | 29.03.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Xiamen University No. 422, Si Ming Nan Road Siming District Xiamen, Fujian 361005 / CN | For all designated states Yang Sheng Tang Company, Ltd. Room 205, No.17 Lundu Road Shuangpu Town, Xihu District Hangzhou, Zhejiang 310000 / CN | [2022/13] | Inventor(s) | 01 /
LUO, Wenxin No.422 Si Ming Nan Road, Siming District Xiamen, Fujian 361005 / CN | 02 /
JIANG, Yichao No.422 Si Ming Nan Road, Siming District Xiamen, Fujian 361005 / CN | 03 /
YU, Chao No.422 Si Ming Nan Road, Siming District Xiamen, Fujian 361005 / CN | 04 /
CHEN, Xiaoqing No.422 Si Ming Nan Road, Siming District Xiamen, Fujian 361005 / CN | 05 /
TANG, Jixian No.422 Si Ming Nan Road, Siming District Xiamen, Fujian 361005 / CN | 06 /
YUAN, Quan No.422 Si Ming Nan Road, Siming District Xiamen, Fujian 361005 / CN | 07 /
ZHANG, Tianying No.422 Si Ming Nan Road, Siming District Xiamen, Fujian 361005 / CN | 08 /
XIA, Ningshao No.422 Si Ming Nan Road, Siming District Xiamen, Fujian 361005 / CN | [2022/13] | Representative(s) | Meissner Bolte Partnerschaft mbB Patentanwälte Rechtsanwälte Postfach 86 06 24 81633 München / DE | [N/P] |
Former [2022/13] | Held, Stephan Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft mbB Widenmayerstraße 47 80538 München / DE | Application number, filing date | 20808887.2 | 22.05.2020 | [2022/13] | WO2020CN91890 | Priority number, date | CN201910432602 | 23.05.2019 Original published format: CN201910432602 | [2022/13] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020233715 | Date: | 26.11.2020 | Language: | ZH | [2020/48] | Type: | A1 Application with search report | No.: | EP3974446 | Date: | 30.03.2022 | Language: | EN | [2022/13] | Search report(s) | International search report - published on: | CN | 26.11.2020 | (Supplementary) European search report - dispatched on: | EP | 29.06.2023 | Classification | IPC: | C07K16/08, C12N15/13, C12P21/00, A61K39/42, A61K31/20 | [2022/13] | CPC: |
A61P1/16 (EP,CN);
C07K16/082 (EP,CN,KR,US);
A61P31/12 (KR);
A61P31/20 (EP,CN,US);
C12N15/85 (CN);
C12P21/02 (EP);
G01N33/5764 (EP);
A61K2039/505 (CN,KR,US);
A61K2039/575 (US);
C07K2317/24 (EP,CN,US);
C07K2317/30 (EP);
C07K2317/515 (US);
C07K2317/52 (US);
C07K2317/56 (EP,US);
C07K2317/565 (CN,US);
C07K2317/567 (US);
C07K2317/622 (EP,US);
C07K2317/72 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/13] | Title | German: | ANTI-HEPATITIS-B-VIRUS-ANTIKÖRPER UND IHRE VERWENDUNG | [2022/13] | English: | ANTI-HEPATITIS B VIRUS ANTIBODIES AND USE THEREOF | [2022/13] | French: | ANTICORPS DIRIGÉS CONTRE LE VIRUS DE L'HÉPATITE B ET LEUR UTILISATION | [2022/13] | Entry into regional phase | 03.12.2021 | Translation filed | 03.12.2021 | National basic fee paid | 03.12.2021 | Search fee paid | 03.12.2021 | Designation fee(s) paid | 03.12.2021 | Examination fee paid | Examination procedure | 03.12.2021 | Examination requested [2022/13] | 29.01.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 30.05.2022 | Renewal fee patent year 03 | 31.03.2023 | Renewal fee patent year 04 | 28.03.2024 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]EP3360896 (UNIV XIAMEN [CN], et al); | International search | [A]EP2762493 (CHUGAI PHARMACEUTICAL CO LTD [JP]); | [A]CN106046155 (UNIV XIAMEN, et al); | [A]CN106480070 (UNIV XIAMEN, et al); | [X]CN106565840 (UNIV XIAMEN, et al); | [A]WO2018052556 (VISTERRA INC [US]); | [A]CN108456686 (UNIV XIAMEN, et al); | [A]CN108690134 (UNIV XIAMEN, et al); | by applicant | US4816567 | US5225539 | US5530101 | US5585089 | US5693762 | US6180370 |